FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
11/30/2024
Back to search
Official data from USPTO
DBV TECHNOLOGIES
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Quick snapshot
ST13
US500000079364820Class
5, 10, 41, 42, 44
Filing
79364820
Registration
7390034
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
28
Latest update
01/10/2025
Trademark type
Combined
Nice classes
5, 10, 41, 42, 44
Filing date
09/19/2022
Registration date
05/21/2024
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
05/21/2024
Last transaction
01/10/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
3
Owner type
98
Owner location
FR
Examiner
MARTIN, LIEF
Law office
M30
Current location
FILE REPOSITORY (FRANCONIA)
Mark description
The mark consists of the wording 'DBV Technologies' appearing below a design comprised of two concentric circles above a curved line.
Holders and representatives
Holders
D. T. (pessoa física)
Representatives
Jennifer Sheehan Anderson Bridge Intellectual Property Services PL
Technical classification
Nice Classes
Class 5Class 10Class 41Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Medicated adhesive devices in the nature of epicutaneous patches enabling the cutaneous or epicutaneous administration of pharmaceutical or medicated substances in dry form for humans and animals for the treatment and prevention of allergiesautoimmuneinflammatory and infectious diseases; epicutaneous patches containing powdered preparations for medical use for the treatment and prevention of allergiesautoimmuneinflammatory and infectious diseases; medicated occlusion patches in the nature of epicutaneous patches enabling the absorption of powdered medicated substances through the skin for the treatment and prevention of allergiesautoimmuneinflammatory and infectious diseases
Class 10
Medical apparatusinstruments and devicesepicutaneous patches sold without medication for the cutaneous or epicutaneous administration of medicated or cosmetic substances in dry form for humans or animals; occlusion patch dispensers for medical use; medical instruments using the electrostatic properties of biocompatible mediaepicutaneous patches sold without medication
Class 41
Educational services for consumers and professionals in the field of immunotherapyorganizing classesseminarsprogramsconferencescongressesworkshops in the field of immunotherapy; organizing and providing exhibitions for online educational purposes featuring interactive presentations and exhibitions in the field of immunotherapy; publishing periodicalsbooksguides in the field of immunotherapy; database publishing servicesnamely publishing of periodical journals containing printed databases in tabular form in the field of immunotherapy; providing information with respect to education in the field of immunotherapy via an online website
Class 42
Medical and scientific research in the field of immunotherapydeveloping scientific methods for epicutaneous immunotherapyto try to treat and prevent autoimmuneinfectious and inflammatory diseases without prior preparation of the skin other than a simple rapid cleaning in order to leave the cell structure of the skin intact; scientific research in the field of allergy treatment and care; scientific research in the field of allergy treatment for the repeated application of treatments to patients' skin without prior preparation of the skin other than a simple rapid cleaning in order to leave the cell structure of the skin intact and thus avoid the passage of allergens into the blood; allergenic drug discovery services; medical and scientific research servicesdeveloping methods for treating allergies via contact between allergens and skin immune cells; medical and scientific research servicesdeveloping methods for the treatment and prevention of allergiesautoimmuneinfectious and inflammatory diseases by applying patches to patients' unbroken skin without prior preparation of the skin other than a simple rapid cleaning in order to leave the cell structure of the skin intact
Class 44
Medical services using desensitization methods on the principle of immunotherapy; medical treatment and prevention of allergiesinflammatoryautoimmune and infectious diseases through the administration of allergensantigens using patches affixed to the patients' unbroken skinthus avoiding the transfer of allergens into the blood; medical treatment and prevention of allergiesinflammatoryautoimmune and infectious diseases using epicutaneous methods of desensitization via immunotherapy; epicutaneous medical treatments and prevention of allergiesinflammatoryautoimmune and infectious diseases without prior preparation of the skin other than a simple rapid cleaning in order to leave the cell structure of the skin intact; medical consultancy in the field of desensitization to allergies with respect to desensitization to combat allergies
Publications
History of USPTO decisions and trademark events.
28 publications found
FICS
FINAL DISPOSITION NOTICE SENT TO IB
11/09/2024
FIMP
FINAL DISPOSITION PROCESSED
11/09/2024
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
08/21/2024
ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
07/13/2024
NREP
NEW REPRESENTATIVE AT IB RECEIVED
06/15/2024
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
05/21/2024
R.PR
REGISTERED-PRINCIPAL REGISTER
05/21/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
03/05/2024
PUBO
PUBLISHED FOR OPPOSITION
03/05/2024
GPNX
NOTIFICATION PROCESSED BY IB
03/04/2024
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
02/14/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
02/14/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
02/14/2024
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
02/14/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
01/26/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
01/24/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
01/24/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
01/24/2024
RFNT
REFUSAL PROCESSED BY IB
08/29/2023
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
08/09/2023
RFRR
REFUSAL PROCESSED BY MPU
08/09/2023
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
07/05/2023
CNRT
NON-FINAL ACTION WRITTEN
07/04/2023
DOCK
ASSIGNED TO EXAMINER
06/29/2023
MAFR
APPLICATION FILING RECEIPT MAILED
03/21/2023
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
03/17/2023
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
03/09/2023
Continuous trademark protection
Get notified about every new filing that threatens DBV TECHNOLOGIES or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.